No Picture
News

Androvia LifeSciences Presented Data, Providing Scientific Insights that Support Clinical Utility of Cap-Score™, a Validated and Consistent Measure of Fertility

Research presented at 47th Annual Conference of the American Society of Andrology (ASA) demonstrates ability of Cap-Score Test to measure and predict a man’s fertility LA JOLLA, Calif., May 16, 2022 /PRNewswire/ — Androvia LifeSciences […]

No Picture
News

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

SAN DIEGO and SHANGHAI, May 15, 2022 /PRNewswire/ — Inmagene Biopharmaceuticals (“Inmagene”) announces that today the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug candidate IMG-004, a […]

No Picture
News

Pfizer’s $11.6B wager; TIGIT implosion; An unusual pharma-biotech pact; Inside a16z’s vision to reshape biotech; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

No Picture
News

Hydralyte Announces Investment and Brand Collaboration with Actress and Entrepreneur, Shay Mitchell

SAN DIEGO, May 13, 2022 /PRNewswire/ — Today Hydralyte, one of the world’s most trusted rapid hydration solutions, announces a multi-year collaborative partnership with actress, producer and entrepreneur, Shay Mitchell. Mitchell joins the Hydralyte team […]

No Picture
News

Kintara Therapeutics Announces Fiscal 2022 Third Quarter Financial Results and Provides Corporate Update

SAN DIEGO, May 13, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its […]

No Picture
News

Neurocrine Biosciences Receives Orphan Drug Designation for Valbenazine as a Treatment for Chorea Associated with Huntington Disease

SAN DIEGO, May 12, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for valbenazine as a treatment for […]

No Picture
News

Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2022

SAN DIEGO, May 12, 2022 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced […]

No Picture
News

Inhibrx To Host Webcast Presentation of Topline Results from the Phase 1 Trial of INBRX-101, its Optimized Recombinant Human AAT-Fc Protein for the Treatment of Alpha-1 Antitrypsin Deficiency

Event to be webcast live on Monday, May 16, 2022 at 1:30 p.m. PT SAN DIEGO , May 12, 2022 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development […]

No Picture
News

Lineage Cell Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and operating results for the first quarter […]

No Picture
News

Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced financial results for the […]

No Picture
News

Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-targeting CAR-T GC012F in RRMM and B-NHL and CD19/CD7 Dual-directed Allogeneic CAR-T GC502 in B-ALL at EHA2022 Congress

SAN DIEGO, Calif., SUZHOU and SHANGHAI, China , May 12, 2022 /PRNewswire/ — Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell […]

No Picture
News

Pipeline Therapeutics to Present at Multiple Investor Conferences in May 2022

SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that company management will present at the following investor conferences: 2022 RBC Capital Markets Global Healthcare Conference Wednesday, May 18, 2022 at […]